NCI-CCC Tumor Board Question   

These are questions being discussed by academics at NCI-Cancer Centers

Questions discussed in this category



PUMP-2 trial combined FUDR via HAIP with gemcitabine and cisplatin, no immunotherapy was on the protocol. 

For example, a large iliac or sacral plasmacytoma causing symptoms. Both medical oncologists and radiation oncologists get nervous about RT-related cy...

For example: eyeball test, simplified frailty assessment (Facon et al.), IMWG frailty score, ECOG only?

Ampullary carcinoma is not in the NCCN guidelines. Please address not only the role for therapy but the optimal regimen (i.e. Gem based, vs mFOLFIRINO...

At the time of initial diagnosis, there was no clear CNS involvement. When it became clinically apparent disease was refractory to EPOCH, there was CS...

Do you only offer it for patients with a documented IgG < 400? Do you check the IgG at all, or are you doing primary prophylaxis?

The FDA package insert suggests 2.5 mg daily in these settings, while the PrE1003 study demonstrated that a higher dose is feasible. Many oncologists ...

There are some retrospective data that CPCs are associated with worsened outcomes after transplantation. Anecdotally, CPCs could be collected as part ...

How aggressive should we be in bringing elevated plasma/urine 5HIAA to normal levels in patients whose symptoms are controlled? Before we have the res...

DLCO 65% that is of unclear etiology but not due to disease and no cardiac or pulmonary functional limitations.

As immune checkpoint inhibitors have expanded into the neoadjuvant breast cancer setting, severe and unexpected autoimmune toxicities may cause delays...

Most would argue that gain(1q) in combination with another high-risk feature constitutes ultra-high-risk multiple myeloma, and most would argue (with ...

The OS benefit with Zometa was seen only in patients with myeloma bone disease achieving less than or equal to a partial response. SRE risk reduction ...

For many clinical trials, a screening bone marrow biopsy is necessary to get a new baseline. Do you do the same in real-world practice?

Previous questions have focused on the newly diagnosed setting and choice of bisphosphonate versus denosumab. IMWG guidelines do recommend resuming zo...

For a patient with high risk disease and a severe enough reaction that additional taxane-based therapy is contraindicated, do you consider alternate c...

If CCRT is pursued, would you move forward with durvalumab consolidation? Assume the patient with ECOG PS 0 and no co-morbidities. How might this chan...

Please assume that IVIG is fine (as it is for many Jehovah's Witness patients, since IgG is often not considered a blood product per se).

Do you feel differently about using these in patients with a history of HR-negative breast cancer?

Would you consider this de novo DLBCL (unable to assess for clonality)? How would you handle prior anthracycline exposure? 

Young healthy patient, ER/PR positive HER2 negative right breast cancer with a synchronous single site of oligometastatic disease in the right 4th rib...

Patients are understandably concerned about the risks and benefits of radiation to an oozing, bleeding, and ulcerated breast.

Is the therapeutic purpose of the proteasome inhibitor to maximize total dosage per week or number of infusions per week?

What type of adjuvant chemotherapy would you offer? Would clinically positive lymph nodes or residual disease at the time of surgery change your decis...

Following SRS to the brain lesions, is it safe to closely follow the patient for recurrence?

This question seems quite specific but happens quite often. Multi-drug chemotherapy runs the risk of profound cytopenias and infections, while bispeci...

Patient is pre-menopausal and has cT3cN1, grade 2, ER positive, Her 2 negative IDC. Metastatic disease to axillary LNs was biopsy-proven. Patient was ...

Do you utilize rituximab or any other specific management strategies?

Would you prefer CAR-T or bi-specific or neither? If CAR-T, how do you approach lymphodepletion? 

Which PI and at what dosing intervals? Dexamethasone or not? Emory has now published data with VRd consolidation as well as KPd consolidation, while ...

240-300 mg/m2 prior exposure. How would your management change in young fit/older individuals with comorbidities? Would you obtain interval TTE during...

What imaging modality do you use (conventional, PSMA PET, etc.)? When do you image (ex: a PSA threshold or PSADT)?

Ex. TP53, BRCA, T790M, or another? As of now, T790M mutation is one of the few de novo mutations found in treatment naïve patients that have been...

Do you incorporate PEG-asparaginase or brentuximab vedotin (for CD30-expressing malignant cells) into anthracycline-based induction regimens? Do you c...

Would you treat this as a locally advanced breast cancer and offer surgery, radiation, and systemic therapy? Does your management change depending on ...

If tolerated through Cycle #1, how aggressively do you try to titrate the selinexor dose up toward 100mg weekly or 80mg twice-weekly? And does your a...

In light of CheckMate 816 and IMpower010 and FDA approval for neoadjuvant chemo-nivolumab and adjuvant chemo-atezolizumab, how do you decide which sys...

NGS without any actionable mutations and PD-L1 TPS 15%. Would you offer chemotherapy, radiation, or immunotherapy and, if so, in what order?

How much weight do you give to a hgb/hct threshold versus symptoms?

Patient is young. Bilirubin normalizes when tucatinib is held, but again increases to grade 2 when it is restarted. Evaluation for hemolysis was negat...

<60y/o, grade 1 endometrioid endometrial cancer. TLH, BSO, sentinel nodes. Stage IA, focal LVSI, 20% myometrial invasion, negative sentinel nodes, ...

In this case, the patient had received daratumumab/lenalidomide/dexamethasone as part of a cooperative group trial. Would you say that the patient had...

Patient is a post-menopausal woman with 4 lymph node mets that was strongly ER+/PR+, HER2-negative invasive ductal carcinoma with a high Ki-67 w...

Do you routinely offer post-operative adjuvant radiation in addition to chemotherapy? Are the results of the recently published negative phase II...

Is there anything to differentiate the two agents? CNS penetration reportedly with adagrasib, FDA accelerated approval has been given with sotorasib.&...

If so, how many cycles would you give? Both the MAGIC and FLOT trials showed difficulty with administering adjuvant chemotherapy.

Would you use it for initial staging or at time of biochemical recurrence?

Would you consider definitive local therapy (surgery, radiation?) if she achieved a good response to initial systemic therapy?

Does a progressing kappa/lambda ratio > 100 at any point in time warrant treatment, or does one wait to treat patients in the setting of a slowly i...

Patient has been on pembrolizumab and had two symptomatic soft tissue mass treated with radiation. 

Patient is young and reoccurrence is one year after initial diagnosis of T1cN0 ER/PR positive, HER2-negative breast cancer treated with mastectomy, bu...

Frailty Index per Palumbo et al. PMID 25628469Is it practical to apply in clinics? Have you made decision changes based on it?

Patient underwent mastectomy for DCIS in the setting of previous lumpectomy and adjuvant radiation for the invasive breast cancer. 

Venetoclax has demonstrated efficacy in patients harboring t(11;14) mutations but is not FDA approved for MM. Can you expand on what situations you ma...

Patient has already received neo/adjuvant treatment with AC, paclitaxel, capecitabine, docetaxel, and carboplatin.

Would you consider neoadjuvant or adjuvant treatment and if so, which therapies? Patient initially had pT2N0 disease and recurrent disease is also ER+...

Patient previously received neoadjuvant ddAC-T with residual disease at surgery, followed by adjuvant capecitabine which was completed 2 months prior ...

Pathology details: 75% high grade large cell neuroendocrine tumor of the cecum (20-30 mitoses per 10 hpf, Ki67 75%) and 25% adenocarcinoma. Patient ha...

For example: shorten IMiD duration each cycle, add scheduled G-CSF, add antibacterial prophylaxis, etc.

Do you observe, offer adjuvant pembrolizumab, or give a first-line metastatic regimen (IO/IO or IO/TKI)? Does your recommendation vary based on risk c...

CAR-T (any specific preference of product?) vs bispecific antibodies vs any other specific agents not previously utilized?

PSA rose from 25 to 30 ng/mL over 6 months on darolutamide for M0 CRPC, prompting scans which showed oligometastatic disease to bone, not amenable to ...

If any clinical benefit (ie. CR, PR or SD) would you consider switch maintenance avelumab, surveillance until progression, or an alternate regimen?

Molecular profiling revealed no targetable alterations, however tumor mutational burden was >10 mut/Mb.

Patient in mid-30s with no major medical history presented with isolated left neck swelling. Incisional biopsy w/ HTLV1/2 associated ATLL, Ki67 of >...

Patient has progression of liver metastases while on pembrolzumab/axitinib. ECOG PS 1 and limited comorbidities.

GS 4+4. PSA low (1-2). CT and bone scan negative for lymphadenopathy or metastatic disease.  Prostate MRI pending. 

Colleagues in surgery have raised concerns about post radiation effects in the pelvis with the ordering of short course RT->chemo ->surgery.

Is there any role for denosumab? How do you counsel patients regarding the benefit of bisphosphonates on breast cancer outcomes?

Does patient age effect your approach? Would you consider RPLND for any patients in light of the phase II SEMS trial presented at the 2021 ASCO GU Ca...

Patient with T2N1 disease and isolated liver metastases. Axilla and liver completely responded to chemo + IO, but limited residual breast enhancement ...

Do prior treatments for mHSPC change your thinking on whether or not to use sipuleucel-T?

History of CDH1 mutation and prophylactic gastrectomy in 2017 - no other primary site found beyond vagina at diagnosis. Vaginal tumor completely resp...

Would you consider afatinib? Afatinib has shown some activity in NRG1 fusion + patients but amplifications is unclear. 

<40y/o female w/ initial biopsy showing G3 IDC with 80% ER+, 90% PR+, and HER2 positive (IHC 2+; 1.6 HER2/CEP17 ratio and 6.3 HER2 copies/nucleus.)...

Would you plan straight pediatric dosing using 2500 Units/m2 or a cap of 3750 Units as used in some adult ALL regimens due to excess liver/pancreas to...

What clinicopathological features would need to be present for you to recommend adjuvant chemotherapy? Would you treat pT3 disease? Any specific histo...

Specifically, would you offer salvage radiation to a patient who underwent a prostatectomy with PLND and had a post-op PSA of 12 with pathology reveal...

Would you offer this patient chemotherapy? What are your thoughts about OFS plus AI and avoiding chemotherapy?

Would you choose to incorporate HER2-targeting agents, chemotherapy, endocrine therapy, or a mix of these?

I am considering every 6 week pembrolizumab dosing in patients >70 years old in whom I want to reduce clinic visits for, especially in the context ...

Are there particular patient characteristics (e.g. age, ER%, Ki67, grade) that make you more likely to choose neoadjuvant endocrine therapy?

Do features such as nodal involvement, Ki-67, degree of ER positivity, etc. change your management? Would you use any gene expression assays to help y...

Are there any data to support a specific TKI therapy for non-T790M exon 20 mutations/insertions?

How would you approach additional systemic therapy? Would the clinical stage of the cancer affect your management?

Specifically, for cT2N0M0 small cell bladder cancer without response to neoadjuvant cisplatin and etoposide on imaging, would you proceed with cystect...

Is adjuvant radiation and/or adjuvant chemotherapy indicated? 

Would you consider an Oncotype or Mammaprint? Would your management change if the patient had 1-3 positive LNs on SLNBx (as opposed to ALND)?

Tumor felt to be technically unresectable due to extensive cervical/parametrial involvement. ER/PR and HER2 testing are pending.

For patients with low risk, early stage, HR+/HER2- breast cancer who initiated endocrine therapy in order to delay their surgery due to the COVID 19 e...

Patient had a clinical T2N0 cancer at diagnosis, completed 6 cycles TCHP, and had 0.2mm residual disease with 80% cellularity, negative sentinel node.

For example, will you recommend a certain vaccination timing in relationship to their treatment? Any concerns for reduced immune response or risks of ...

Does tumor size impact your recommendation? High grade? Young patient age?

Does the advent of more effective therapies like peptide receptor radioligand therapy (PRRT) and capecitabine and temozolomide (CAPTEM) dampen enthusi...

The patient went straight to gastrectomy for clinical T1 gastric adenocarcinoma, but post-op was up-graded to T4 disease.   Both ARTIST and Inte...

Pre-menopausal women make progesterone and their menses are typically lighter on tamoxifen because it's a mild endometrial ER stimulant blocking their...

The patient remains without evidence of systemic disease outside of the CNS on serial imaging. Would you continue treating with SRS as lesions appear,...

She had had 4 prior biopsies. Would the fact that she received 2 months of neoadjuvant tamoxifen due to COVID change your approach?

Is there any evidence for sacituzumab govitecan (IMMU-132) in this situation with progressive systemic disease after prior anthracycline and taxane?

This patient underwent mastectomy and ALND (10/28 positive lymph nodes). Immediately following axillary LN dissection (and prior to radiation) imaging...

Data from the SOFT/TEXT trials showed clinical benefit in ovarian suppression + aromatase inhibition for high risk, premenopausal ...

Would you treated with local therapies (RFA or SRS) and continue pembrolizumab or would you move to second line treatment?

Would you consider genomic assays before neoadjuvant chemotherapy? How would you modify your treatment given the COVID-19 pandemic?

Upfront surgery vs neoadjuvant therapy? And if neoadjuvant therapy, which regimen? Patient has a good PS.

What are the risks of infection with COVID-19 if using immunotherapy?  

Should staging and treatment decisions be made based on imaging alone?

Personally, my practice is to guide patients directly to surgery or to do neoadjuvant chemotherapy rather than to do neoadjuvant endocrine therapy, bu...

For example, if you had a triple positive breast cancer found on breast biopsy and repeat ER/PR/HER2 testing at the time of surgical resection showed ...

This patient is interested in conceiving and therefore would like to wait to start the tamoxifen.

For example, if a patient had testosterone pellets injected, perhaps making endocrine therapy less efficacious, would that sway you to use chemo?

Being that this is a favorable histology would you use Oncotype Dx to help decide on neoadjuvant chemotherapy? Would you recommend neoadjuvant endocri...

Most trials establishing CRT as standard of care for IIIB NSCLC excluded patients with separate ipsilateral lung nodules given that they were categori...

In your experience, what approach has been successful to bridge to surgery?

Especially if you don't have trials available at the moment. Would you try off-label erdafitinib (given recent data on bladder cancer) or 2nd line ge...

If so, for what platelet count threshold and do you have a preference as to which agent?

In the absence of a frontline clinical trial, would you treat with carboplatin+pemetrexed+pembrolizumab or consider IMPOWER 150 or other?

Knowing that benefit of contralateral mastectomy is lower in older women who has already manifested BRCA related cancer and 10-20 % mastectomy related...

What would be the next line of treatment, PRRT, capecitabine and temozolomide or other?

In a patient with lung cancer with both NSCLC and SCLC components, would you offer carbo/pem/pembro or carbo/etoposide/atezolizumab? Or any other alte...

The NCCN guidelines regard  MET exon 14 skip mutation   as an emerging biomarker but no formal recommendation to start crizotinib. If high P...

Is this new SSO choosing widely guideline being widely adopted and are there any concerns regarding this for clinical practice?

If yes, would you still recommend dual HER2 directed therapy? After the TRYPHAENA trial, neoadjuvant therapy with dual HER2 directed therapy has beco...

Given that DBA is associated with increased incidence of MDS, AML and other solid tumors, would this modify your treatment recommendations?

For early stage disease in a single breast, would you consider neoadjuvant chemotherapy or upfront surgical staging followed by adjuvant therapy? What...

Given the potential high risk of developing pneumonitis with TKI post checkpoint inhibitor, do you avoid TKIs and try a different regimen (ex carbo/pa...

Provided the sternal lesion was low volume and treated with curative intent and patient has been on tamoxifen for < 5 years, would you switch to AI...

Tamoxifen prophylaxis has not been studied in women <35 years old, but it would be reasonable to assume they would benefit.

In a patient with who had undergone neoadjuvant TCH-P, lumpectomy, and RT and is currently on AI, pertuzumab, and trastuzumab, how do you think about ...

In clinical practice, consolidation chemotherapy is sometimes used, though this was not implemented in the PACIFIC trial.Antonia et al., PMID 28885881...

 If so, would you treat as node + BC with  anthracycline and taxane regimen or   non-anthracycline regimen (i.e  docetaxel and cyc...

Retrospective data suggest clinically significant disease flare after tyrosine kinase inhibitor discontinuation in patients with EGFR-mutant lung canc...

Is there a point at which there may be no benefit? More than 3 months from breast surgery? 6 months? 1 year?

Would you maintain dose density of chemotherapy and use peg-filgrastim prior to delivery of the baby? Would you defer taxane and anti-HER2 therapy unt...

If so, what would be the regimen that you would consider and what factors would sway you for or against chemotherapy for such patients?

No other site of metastatic disease. It is unclear if this situation should be managed as two separate primaries or metastatic disease.

Do your recommendations differ if patients are pre or postmenopausal given the data?

Does the answer vary based on whether it is neo/adjuvant or metastatic setting?

Carbo/pemetrexed/pembrolizumab, carbo/pemtrexed without immunotherapy or second line immunotherapy (Nivo, Pem or atezolizumab)?

There is no evidence of disease outside the lung on PET, and the patient is completely asymptomatic with negative EGFR, ALK, ROS1, and BRAF and a PD-L...

PD-L1 < 50% and no targetable mutations. Would you use carbo/pemetrexed/pembrolizumab or Nivolumab or pembrolizumab?

Lung primary is inaccessible for biopsy and metastatic sites are only 2 small bone lesions. In a non-smoker, a driver mutation is suspected but would ...

In a patient treated over 10 years ago with mastectomy and chemo now with recurrence in the ipislateral axilla, would you offer additional with chemot...

Certainly ovarian cancer will respond to carboplatin and paclitaxel and it sounds like a reasonable chemotherapy to give to a stage IV NSCLC, however ...

Would you do this for ER+ patients? According to the PERSEPHONE trial presented on ASCO 2018, in HER2+, non-metastatic breast cancer, 6 months Hercep...

If there is no response to neoadjuvant AC -->T, would you offer additional adjuvant chemotherapy?

Do you offer additional adjuvant chemotherapy, proceed to adjuvant endocrine therapy, or search for a suitable clinical trial?

Patient does not qualify for breast cancer screening by annual MRI per criteria (IBIS lifetime risk<20%, no known genetic predisposition,...

When would you favor delivering local therapy (e.g. SBRT) prior to systemic therapy?

These patients have been largely excluded from these trials.  What if the infection is well controlled?

An article (BRCA mutation and outcome in BC. Ellen Copson, et al. Lancet Oncol. 2018) showed G3, BRCA+ breast cancer had poorer prognos...

If so, when? Are there certain ERBB2 mutations that would predict response to trastuzumab and/or neratinib? 

Following the dosage guidelines based on absolute neutrophil count may cause the patient to end up receiving lower doses.

This is in regards to the risk of secondary cancers after radiation therapy or cytotoxic chemotherapy (such as anthracyclines) in an immunosuppre...

What do you do with low grade (grade 1/3) tumors? In other words, does high grade pathology over rules?

Would you use a regimen with lower incidence of neurotoxicity such as CMF or a taxane-based regimen with a low threshold to dose-reduce?

Some patients request chemotherapy scheduling adjustments to avoid feeling ill on major holidays. Delaying chemotherapy by a few days isn't of particu...

Example case: Patient given neoadjuvant docetaxel + cyclophophamide achieves a partial response after 3 cycles of Taxotere + cyclophosphamide but is u...

Tamoxifen prophylaxis is FDA-approved, but would you extrapolate from adjuvant/metatastic data for hormone receptor positive breast cancer in post-men...

In the absence of data demonstrating a clinical benefit for one strategy versus the other, what do you do in practice?  

There is limited data that suggests steroidal AI exemestane could be of some benefit after nonsteroidal AI failure (Lonning PE et al. J Clin Oncol 200...

I.e. either for treatment of high-risk disease or intolerance/contraindication to tamoxifen. Will you continue it for the full 5 year course?

In a patient with isolated leptomeningeal disease (no systemic disease), would you still recommend systemic therapy?

Do you reserve this approach for only women with triple negative breast cancer or all-comers?

What would you choose if there is no response to neoadjuvant AC-T? Taxol, THP, TCHP?

(For instance, TCX4 instead of AC->T for smaller tumors?)Does this affect your decision about treating with neoadjuvant versus adjuvant chemotherap...

How would the new data presented at ASCO GI 2021 from from Alliance A021501 influence your answer?

At what point do you send these test, and in what instances do the results influence your treatment recommendations?

Would you offer adjuvant TKI following ADAURA data?  Or proceed with durvalumab based on PACIFIC data?


Papers discussed in this category


International journal of radiation oncology, biology, physics, 2013-03-15

International journal of radiation oncology, biology, physics, 2011-05-01

International journal of radiation oncology, biology, physics, 2011-11-01

The New England journal of medicine, 2015-03-05

N. Engl. J. Med., 2015-01-29

Lancet, 2007-05-19

The Lancet. Oncology, 2016-12

Nat. Med.,

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018-02-01

Clinical breast cancer, 2006-12

Lancet (London, England), 2009-12-19

The Lancet. Oncology, 2014-06

The New England journal of medicine, 2012-11-08

J. Clin. Oncol.,

European radiology, 2022 May 07

The Cochrane database of systematic reviews, 2020 Dec 21

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003-03-15

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009-03-10

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017-08-10

J. Clin. Oncol., 2019 Oct 16

N. Engl. J. Med., 2017-07-13

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2015-04

Am J Case Rep, 2017-02-28

The New England journal of medicine, 2016-08-25

Lancet, 2017-09-09

Annals of oncology : official journal of the European Society for Medical Oncology, 2013-09

Oncologist, 2007-09-01

Journal of the National Cancer Institute, 2006-12-20

Medicine and science in sports and exercise, 2010-07

J Clin Oncol, 2016 Feb 20

Curr Breast Cancer Rep, 2016-01-01

Crit Rev Food Sci Nutr, 2018 Apr 19

JAMA, 2018-02-20

JAMA Oncol,

The New England journal of medicine, 2012-08-02

Lancet (London, England), 2016-12-17

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016-09-01

Breast cancer research and treatment, 2012-11

N Engl J Med,

British journal of clinical pharmacology, 2016-06

The New England journal of medicine, 2014-07-10

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016-07-01

Fertility and sterility, 2016-03

Breast Cancer, 2017-09-01

Journal of the National Cancer Institute, 2010-07-07

J Natl Cancer Inst, 2006 Jul 5

J. Natl. Cancer Inst., 2010-07-07

J. Clin. Oncol., 2003-10-01

Breast Cancer Res. Treat., 2005-01-01

Breast, 2016-12-01

Zhonghua Zhong Liu Za Zhi, 2016-07-01

Breast, 2016-08-01

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016-05-10

Cancer, 2010-11-15

The breast journal, 2017-11

The New England journal of medicine, 2011-06-23

Lancet (London, England), 2016-02-27

Cancer investigation, 2011-11

Clinical cancer research : an official journal of the American Association for Cancer Research, 2009-12-01

Cancer Treat. Rev., 2011-10-01

Annals of oncology : official journal of the European Society for Medical Oncology, 2015-07

Ann. Oncol., 2013-12-01

Nat Rev Clin Oncol, 2016-08-01

The Lancet. Oncology, 2018-02

N. Engl. J. Med.,

Ann. Oncol.,

Clin. Cancer Res., 2018 Mar 26

Science translational medicine, 2013-12-18

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2013-02

Ann. Oncol.,

Int J Radiat Oncol Biol Phys, 2023 Mar 01

Breast Cancer, 2012 Apr 25

Annals of surgical oncology, 2018-10

Lancet Oncol., 2015 Sep 09

J Clin Oncol, 2022 Jan 07

JAMA oncology, 2019-06-01

Lancet Oncol, 2021 Jun 11

Cancer, 2004-10-15

The New England journal of medicine, 2018-12-13

Lancet Oncol., 2016 Jun 23

BMJ, 2016 Sep 30

The New England journal of medicine, 2018-07-12

Journal of the National Cancer Institute, 2017-02

N Engl J Med, 2015 Jan 8

Annals of internal medicine, 2018-01-16

N Engl J Med, 2017 Nov 16

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008-12-10

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018-04-10

The Lancet. Oncology, 2012-07

Annu. Rev. Med., 2015 Aug 28

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017-06-20

Lancet,

Lancet Oncol, 2019 Feb 19

Lancet Oncol, 2019 Dec 02

Lancet Oncol, 2017 Oct 13

JNCI Cancer Spectr, 2021 May 28

Lancet (London, England), 2013-03-09

The New England journal of medicine, 2018-07-12

Cancer, 2006-09-15

Cancer Discov,

Clin. Cancer Res.,

N. Engl. J. Med.,

J Clin Oncol, 2022 Apr 11

The New England journal of medicine, 2016-07-21

The Lancet. Oncology, 2019-01

The Lancet. Oncology, 2017-12

J Thorac Oncol, 2016 Jul

Eur. J. Cancer, 2017 Aug 04

J Thorac Oncol, 2018 Feb

J. Clin. Oncol., 2018 Jun 15

The Lancet. Oncology, 2015-02

J. Clin. Oncol., 2017 Dec 14

NPJ breast cancer, 2017

The New England journal of medicine, 2018-06-14

N Engl J Med, 2018 Oct 20

The Lancet. Respiratory medicine, 2017-11

Ann. Thorac. Surg.,

Annals of surgical oncology, 2009-06

Annals of surgical oncology, 2017-02

Breast Cancer Res. Treat., 2017 Sep 15

JAMA, 2011-11-02

The New England journal of medicine, 2016-11-17

The Lancet. Oncology, 2016-04

Breast cancer research : BCR, 2016-06-28

International journal of radiation oncology, biology, physics, 2009-01-01

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011-12-10

BMC Cancer, 2018 Jan 11

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013-07-01

Annals of surgical oncology, 2011-01

J Clin Oncol, 2011 Jan 10

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015-01-01

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015-07-20

JAMA Oncol,

JAMA Oncol,

J. Clin. Oncol., 2020 Feb 20

J Clin Oncol, 2019 Jun 02

The New England journal of medicine, 2016-11-10

The New England journal of medicine, 2018-05-31

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2019-03-01

The Lancet. Oncology, 2013-10

Breast cancer research and treatment, 2017-06

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016-07-10

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000-04

The journals of gerontology. Series A, Biological sciences and medical sciences, 2001-03

Annals of oncology : official journal of the European Society for Medical Oncology, 2015-02

Medicine (Baltimore),

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017-01

Arch Surg,

Lancet, 1998 Jul 25

Int. J. Radiat. Oncol. Biol. Phys., 2008-11-01

JAMA Oncol,

Lancet Oncol, 2021 Dec 15

N Engl J Med, 2011 Oct 6

Lancet Oncol., 2012-01-01

Annals of oncology : official journal of the European Society for Medical Oncology, 2013-09

JAMA oncology, 2017-05-01

Clinical cancer research : an official journal of the American Association for Cancer Research, 2012-12-15

JAMA oncology, 2017-07-01

J. Clin. Oncol., 2017 Oct 02

The New England journal of medicine, 2015-02-19

Breast Cancer Res Treat, 2009 Jun

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2019-02

JAMA, 2012 Jul 11

Radiation oncology (London, England), 2011-09-28

JAMA surgery, 2019-05-29

J. Clin. Oncol., 2020 Feb 27

Trials, 2013 Aug 19

Ann. Oncol., 2012 Jun 06

Cancer,

Annals of surgical oncology, 2014-10

N. Engl. J. Med.,

Ann Surg Oncol, 2022 Apr 04

Clin Transl Oncol, 2018 Mar 28

Eur J Haematol, 2023 Mar 27

N. Engl. J. Med., 2017 Jun 04

Clinical cancer research : an official journal of the American Association for Cancer Research, 2017-04-15

The New England journal of medicine, 2019-06-20

The New England journal of medicine, 2018-01-11

N. Engl. J. Med., 2019 May 31

The New England journal of medicine, 2018-12-06

J Thorac Oncol, 2019 Jan 18

The New England journal of medicine, 2019-02-14

N. Engl. J. Med.,

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018-06-01

The New England journal of medicine, 2012-02-09

Cancer control : journal of the Moffitt Cancer Center, 2009-01

JAMA, 2015-07-07

Clinical cancer research : an official journal of the American Association for Cancer Research, 2019-08-01

Nat Commun, 2019 Mar 27

Annals of surgery, 2019-04-05

The Lancet. Oncology, 2010-01

Breast Cancer Res. Treat.,

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013-09-01

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2004-06-15

J. Natl. Cancer Inst.,

PLoS ONE, 2018 May 16

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2019-08-01

International journal of radiation oncology, biology, physics, 2007-07-15

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2004-12-01

Lancet Oncol., 2015-03-01

Ann. Surg. Oncol., 2013 Nov 23

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015-01-01

Lancet Oncol., 2014-06-01

Clinical cancer research : an official journal of the American Association for Cancer Research, 2017-02-01

Breast, 2013 Dec 22

Breast, 2015 Oct 09

Cancer,

J. Clin. Oncol., 2013 Aug 26

Annals of oncology : official journal of the European Society for Medical Oncology, 2019-08-01

Cancer, 2005-04-15

Lung cancer (Amsterdam, Netherlands), 2015-12

Nature medicine, 2018-05

Cancer, 2017-11-01

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018-08-20

Lancet (London, England), 2019-05-04

Annals of oncology : official journal of the European Society for Medical Oncology, 2015-07

European journal of cancer (Oxford, England : 1990), 2019-03

Lancet Oncol, 2019 May 20

Lung Cancer, 2012 Feb 10

N. Engl. J. Med., 2019 Sep 28

JAMA, 2014-05-21

Clin. Cancer Res., 2019 Aug 15

Ann. Oncol.,

Gastroenterology, 2018 May 17

Clin. Gastroenterol. Hepatol., 2018 Nov 28

Hepatology (Baltimore, Md.), 2019-10

Cancer, 2011-11-01

Case reports in oncology, 2017

BMC Cancer, 2015 Oct 15

JAMA oncology, 2019-06-01

Int J Cancer, 2018 Apr 15

JAMA Oncol, 2019 Oct 31

Eur J Surg Oncol, 2014 Oct 07

Breast cancer research and treatment, 2017-08

Ann. Oncol.,

The Lancet. Oncology, 2018-01

Annals of surgical oncology, 2018-08

Lancet Oncol., 2020 Feb 14

The Lancet. Oncology, 2010-10

Breast Cancer Res. Treat.,

Lancet, 2019 Oct 04

International journal of radiation oncology, biology, physics, 2005-07-15

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010-04-20

Cancer discovery, 2015-08

Annals of oncology : official journal of the European Society for Medical Oncology, 2018-10-01

Nature, 2014-07-31

Cancer discovery, 2015-08

J Clin Oncol, 2020 May 10

J Thorac Oncol, 2021 Oct 12

J. Clin. Oncol., 2019 Oct 16

Proceedings of the National Academy of Sciences of the United States of America, 2015-11-03

Oncologist, 2020 Mar 10

Semin Diagn Pathol, 2016 Dec 23

Breast cancer research and treatment, 2014-11

The Lancet. Oncology, 2016-03

British journal of cancer, 2005-03-14

Case Rep Oncol, 2020 Jan 21

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012-07-01

The New England journal of medicine, 2001-09-06

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017-04-01

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013-11-01

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009-11-01

Lancet Oncol, 2020 Dec 07

Ann Oncol,

Lancet Oncol, 2021 Apr 13

J. Thorac. Cardiovasc. Surg.,

Cancer, 2015 Jan 06

Eur J Cardiothorac Surg,

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012-07-20

Clinical cancer research : an official journal of the American Association for Cancer Research, 2018-12-01

JAMA Oncol, 2020 Aug 13

Journal of the National Cancer Institute, 2005-11-16

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018-05-10

N Engl J Med,

Lancet Oncol.,

British journal of cancer, 2011-06-07

N Engl J Med, 2021-04-01

Cancer, 2020 Jun 10

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006-08-10

Journal of the National Cancer Institute, 1997-11-19

Journal of surgical oncology, 2017-06

Annals of oncology : official journal of the European Society for Medical Oncology, 2000-08

Lancet Oncol., 2018 Nov 06

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001-03-15

Clin Nutr, 2015 Aug 28

Obstet Gynecol,

JAMA,

Cancer Prev Res (Phila), 2019 Aug 16

The New England journal of medicine, 2017-01-12

Seminars in oncology, 2018-08

Endocrine-related cancer, 2016-09

Pancreas, 2017-07

JAMA Oncol, 2020 Apr 16

Pancreas, 2020 Jan

Surg Oncol Clin N Am, 2020 Oct 20

Scand J Gastroenterol, 2019 Aug 01

J Am Coll Surg, 2017 Jan 11

J Clin Oncol, 2018 Jun 07

Lancet Oncol., 2014-11-01

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2019-08-01

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2019-08-01

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014-12-10

N. Engl. J. Med., 2017-07-27

Ann. Oncol.,

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005-02-01

JAMA Oncol,

Urology, 2001-08

Br J Cancer,

The New England journal of medicine, 2016-03-03

Cancer immunology, immunotherapy : CII, 2017-01

Cancer, 2017-06-01

Journal of the American Academy of Dermatology, 2019-07-11

J Immunother,

Oncologist, 2020 Feb 11

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2015-09

J Thorac Dis,

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018-03-10

J Clin Oncol, 2019 Sep 18

Gynecologic oncology, 2014-11

Practical radiation oncology, 2019

Journal of clinical pharmacology, 2010-04

BJU Int, 2011 Oct

Anticancer Drugs,

Cancer, 2010-11-15

Ann Oncol, 2010 Feb 12

N Engl J Med, 2021 Mar 4

Cancer, 2000-03-15

Front Oncol, 2020 Dec 03

Annals of surgical oncology, 2018-07

Clinical genitourinary cancer, 2018-12

J Urol, 2020 Apr

Lancet, 2020 Mar 05

The New England journal of medicine, 2018-07-05

Lancet (London, England), 2018-03-24

J Gastroenterol, 2019 Nov 12

Am Heart J, 2010 Sep 18

N Engl J Med,

Lancet (London, England), 2017-01-07

The Lancet. Oncology, 2019-02

JAMA Oncol, 2020 Dec 10

Hepatology, 2019 Oct 14

Clin Imaging, 2021 Feb 10

N Engl J Med, 2020 May 14

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2019-05-10

The New England journal of medicine, 2017-07-27

JAMA Oncol, 2021 Feb 18

Clinical breast cancer, 2008-06

Clinical genitourinary cancer, 2017-06

The Journal of urology, 2014-02

Journal of the National Comprehensive Cancer Network : JNCCN, 2018-01

Cancer medicine, 2019-01

Journal of the National Cancer Institute, 1988-07-06

Annals of oncology : official journal of the European Society for Medical Oncology, 2015-02

Anticancer Drugs,

J Adolesc Young Adult Oncol, 2019 Nov 08

N. Engl. J. Med., 2018-01-25

N. Engl. J. Med., 2019 Jun 02

N. Engl. J. Med., 2019 May 31

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018-02-01

J. Clin. Oncol., 2019 Jul 22

Breast Cancer Res, 2020 Nov 04

Breast Cancer Res Treat, 2011 Jul 27

Clin Breast Cancer, 2019 May 24

J Clin Oncol, 2020 Sep 16

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009-12-01

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014-07-10

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014-07-10

Oncologist, 2020 Dec 03

International journal of radiation oncology, biology, physics, 2018-10-01

Urology, 2000-11-01

Abdom Radiol (NY), 2019 Aug 29

Ann Oncol, 2007 Nov 15

Cancer Manag Res, 2012 Jun 13

Ann Oncol, 2007 Feb 13

J Clin Oncol, 2021 Feb 04

Biol Blood Marrow Transplant, 2019 Jul 01

Ann Hematol, 2015 Mar 27

Leukemia, 2008-12

Leuk Lymphoma, 2019 Nov 04

Ann Oncol, 2019 Oct 1

Int J Cancer, 2020 Dec 21

Adv Ther, 2020 Oct 29

Lancet, 2021 May 07

N. Engl. J. Med., 2016-10-13

Lancet, 2020 Sep 28

Lancet Oncol,

Lancet Oncol,

J Urol, 2020 Apr 13

Eur J Nucl Med Mol Imaging, 2020 Aug 12

J Urol,

Gynecologic oncology, 2019-06

Gynecol Oncol, 2021 Mar 05

Zhonghua Bing Li Xue Za Zhi,

Am J Transplant, 2016 Jun 09

Transplantation, 2021 Apr 27

Surgery, 2017 Jun 16

JAMA, 2011-02-09

Clinical genitourinary cancer, 2018-06

Cancer treatment and research communications, 2019

Urology, 2013-06

Prostate Cancer Prostatic Dis, 2020 Feb 28

Cancer, 2019 Dec 1

J Clin Oncol, 2021 Feb 02

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016-02-01

Cancer, 2020 Mar 15

J Clin Oncol, 2021 Apr 06

Eur J Nucl Med Mol Imaging, 2018 Sep 28

Br J Radiol, 2018 Mar 20

Eur J Nucl Med Mol Imaging, 2013 Sep 13

BMC Cancer, 2019 Aug 08

Scand J Gastroenterol, 2021 Jan 20

Int J Endocrinol, 2021 Jan 23

Cancer Treat Rev, 2020 Dec 22

Clin Cancer Res,

The New England journal of medicine, 2012-05-10

Nature communications, 2019-04-23

Blood, 2012 Aug 13

J Clin Oncol, 2020 Apr 16

Blood,

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017-10-10

The New England journal of medicine, 2017-04-06

The Lancet. Oncology, 2019-01

Blood,

Lancet Oncol, 2020 Jan

Eur J Cancer, 2020 Jun 27

European urology focus, 2018-12

Int J Radiat Oncol Biol Phys, 2015 Jul 15

Clin Genitourin Cancer, 2019 Mar 28

Int J Radiat Oncol Biol Phys, 2021 Feb 06

Circulation, 1995-08-15

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017-01

Endocrine-related cancer, 2018-03

Lancet, 2021 Jan 21

Ann Oncol,

The New England journal of medicine, 2018-11-08

Eur J Haematol, 2021 Aug 11

Lancet Oncol, 2020 Oct 29

Blood Adv, 2021 Sep 01

Cell,

Am J Hematol, 2021 Jul 05

The Lancet. Oncology, 2018-07

Blood Cancer J, 2020 Mar 09

JAMA Oncol,

JAMA, 2016-11-15

N Engl J Med,

J Clin Oncol, 2019 Apr 10

J Clin Oncol, 2020 Feb 21

J Clin Oncol, 2020 Oct 06

Mol Cell Endocrinol, 2021 Jan 26

Journal of clinical pathology, 2017-09

Leukemia, 2018-06

Int J Cancer, 2018 May 10

J. Clin. Oncol., 2020 Sep 20

Haematologica, 2021 Jun 01

J Urol, 2021 Feb 26

European urology, 2019-06

N Engl J Med, 2020 Sep 18

Cancer, 2020 Nov 20

Ann. Surg., 2019 Aug 30

Annals of surgical oncology, 2019-04

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009-03-10

The New England journal of medicine, 2015-11-05

Haematologica, 2018 May 24

Blood,

Leukemia, 2011 Jul 01

Haematologica, 2019 Sep 19

Blood, 2017 Aug 17

Blood, 2015 May 28

BJU international, 2011-09

Cancer, 2009-09-15

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012-04-01

Clinical genitourinary cancer, 2016-02

Cancer, 2019-05-01

European urology, 2017-07

Int Urol Nephrol, 2007 Mar 02

Clin Genitourin Cancer, 2017 Jul 22

Clin Genitourin Cancer, 2020 Feb 08

Eur Urol, 2019 Nov 08

J Clin Oncol,

Clin Lymphoma Myeloma Leuk, 2020 Mar 07

Clin Lymphoma Myeloma Leuk, 2021 Jul 18

Blood Cancer J, 2021 Jan 11

N Engl J Med,

Blood cancer journal, 2018-06-12

J. Clin. Oncol., 2019 Oct 25

JAMA Oncol,

J Urol, 2020 Jul

Clin Cancer Res, 2020 Jan 22

Cancer, 2021 Apr 21

British journal of haematology, 2014-06

International journal of radiation oncology, biology, physics, 2019-06-01

Annals of oncology : official journal of the European Society for Medical Oncology, 2007-04

Blood, 2018-07-05

Blood,

Blood,

J Clin Oncol, 2021 Jun 25

Eur Urol Oncol, 2019 Sep 19

N Engl J Med,

Invest New Drugs, 2017 Oct 25

Lancet Oncol, 2019 Oct 23

Blood, 2011-09-15

Haematologica, 2011 Dec 01

Cancer Chemother Pharmacol, 2016 Jun 10

Clin Cancer Res, 2020 Aug 17

N. Engl. J. Med., 2012-04-19

British journal of haematology, 2017-11

J Clin Oncol, 2016 Feb 29

Lancet Haematol, 2016 Dec 05

Lancet Oncol, 2022 Jan 21

N Engl J Med,

Annals of Oncology, 2021 Sep 29

Prostate cancer and prostatic diseases, 2018-04

JCO Precis Oncol, 2020

Lancet Oncol, 2019 Sep 09

Cancer, 2019 Jul 18

J Clin Oncol, 2021 Dec 10

The Lancet. Oncology, 2014-02

Front Oncol, 2018 Apr 17

Br J Cancer, 2021 Feb 03

Hepatogastroenterology, 2013 Jan 16

Medicine (Baltimore),

J Clin Oncol, 2022 Jan 18

J Clin Oncol, 2021 Aug 13

Lancet, 2016 Mar 19

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018-04-10

N Engl J Med, 2022 Feb 17

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015-08-20

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014-05-10

Lancet, 2019 Dec 12

Lancet (London, England), 2016-02-27

Blood, 2015-03-26

Clin Lymphoma Myeloma Leuk, 2019 Oct 09

JCO Oncol Pract, 2019 Nov 25

Lancet Haematol,

Leukemia, 2020 Jul 21

Am Soc Clin Oncol Educ Book,

World J Gastroenterol,

Prostate, 2022 Jun 08

Lancet (London, England), 2019-01-19

Lancet Oncol, 2014 Oct 26

Blood cancer journal, 2016-07-29

Leukemia, 2022 Apr 11

The New England journal of medicine, 2018-08-23

Breast Cancer Res Treat, 2016 Feb 18

Mol Cancer Ther, 2018 Mar 28

Eur J Cancer, 2014 Aug 12

N Engl J Med, 2021 Jun 03

N Engl J Med, 2022 Jun 05

Ann Oncol, 2013 Mar 01

N Engl J Med, 2020 Sep 19

Lancet, 2021 Sep 20

N Engl J Med, 2022 Apr 11

Lancet (London, England), 2014-07-12

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012-05-20

N Engl J Med, 2022 Dec 11

J Clin Oncol, 2022 Dec 22

Blood Adv, 2022 May 10

Blood, 2022 Dec 15

Oncotarget,

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011-06-10

Clinical genitourinary cancer, 2018-08

Pediatr Blood Cancer, 2022 Oct 02

Clin Cancer Res, 2023 Jan 09

Journal of the National Comprehensive Cancer Network : JNCCN, 2012-05

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002-09-15

Cancer, 2010-09-15

Pediatric blood & cancer, 2006-03

Pediatric blood & cancer, 2014-04

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009-03-20

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001-05-01

Annals of oncology : official journal of the European Society for Medical Oncology, 2011-02

Pediatric blood & cancer, 2015-01

The Lancet. Oncology, 2018-09

N Engl J Med, 2022 Nov 03

Lancet, 1993 Apr 24

Lancet, 2002 Jun 15

Crit Rev Oncol Hematol, 2014 May 02

Br J Haematol, 2014 Feb 07

Blood, 2023 Apr 27

J Clin Oncol, 2005 Sep 01

J Pediatr Hematol Oncol, 2004 Nov

Hemasphere, 2020 Jan 10

J Pediatr Hematol Oncol, 2001 Jan

Br J Cancer, 1992 Dec

Int J Radiat Oncol Biol Phys, 2001 Dec 01

J Clin Oncol, 2007 Apr 09

Clinical cancer research : an official journal of the American Association for Cancer Research, 2017-01-15

N Engl J Med, 2022 Jun 03

Oncology, 2020 May 28

Ann Surg,

Blood, 2016 Mar 21

Amyloid, 2017 Apr 23

Leukemia, 2015 Oct 07

British journal of haematology, 2017-10

Blood Adv,

Blood Cancer J, 2018 May 24

Amyloid, 2019 Jan 20

Front Oncol, 2021 Apr 29

The New England journal of medicine, 2015-08-13

J Clin Oncol, 2022 Aug 12

Annals of oncology : official journal of the European Society for Medical Oncology, 1993-11

Proc Natl Acad Sci U S A, 2019 Apr 15

N Engl J Med,

Ann Oncol, 2022 Feb 14

N Engl J Med,

Ann Oncol, 2009 Jul 01

Blood, 2010 Jul 21

Lancet (London, England), 2019-06-15

Clin Lymphoma Myeloma Leuk, 2020 Jul 29

Br J Haematol, 2021 Aug 15

Blood, 2022 Dec 08

Chest, 2020 Aug 14

Chest, 2020 Jul

ERJ Open Res, 2020 Oct

N Engl J Med, 2022 Jun 05

J Clin Oncol, 2022 Jun 04

J Clin Oncol, 2022 Oct 21

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 2007-11

Annals of surgery, 2010-03

Cancer, 2016-02-15

Cancer, 2019-01-01

HPB : the official journal of the International Hepato Pancreato Biliary Association, 2017-07

N. Engl. J. Med.,

Leukemia, 2019-03

Journal of the American Society of Nephrology : JASN, 2007-03

Lancet Haematol, 2019 Mar 11

Blood Cancer J, 2022 Sep 02

N Engl J Med, 2022 Jun 03

J Hematol Oncol, 2021 Oct 30

Blood, 2022 Mar 03

Lancet,

N Engl J Med, 2021 Dec 11

Cancer, 2021 Jun 28

Nature reviews. Urology, 2018-04

JAMA Oncol,

Clin Cancer Res, 2019 Sep 11

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2019-06-20

BMC Cancer, 2019 Aug 19

Leukemia, 2022 Feb 21

J. Clin. Oncol., 2018-07-01

The New England journal of medicine, 2023 Jun 04

Nat Rev Urol, 2021 Jan 11

J Clin Oncol, 2022 Aug 30

Lancet Oncol., 2019 Mar 25

Cancer cell, 2017-06-12

J Neurooncol, 2022 Jun 20

N Engl J Med,

J Clin Oncol, 2020 Dec 23

Nat Med, 2020 Apr 06

J Clin Oncol, 2021 Oct 12

Nat Cancer, 2020 Aug 03

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016-05-10

Eur Urol Oncol, 2022 May 20

J Clin Oncol, 2021 Dec 20

Lancet Oncol, 2020 Jun 05

Lancet Oncol, 2022 Jul 12

Lancet, 2021 Jun 24

N Engl J Med, 2023 Jun 05

N Engl J Med, 2023 Feb 10

Lancet Oncol, 2021 Dec 03

Lancet, 2021 Jun 04

Blood, 2022 Oct 20

J Clin Oncol, 2017 Jan 17

Br J Haematol, 2023 Jun 07

Experimental hematology & oncology, 2022 Feb 28

JACC CardioOncol, 2021 Mar 16

JACC. CardioOncology, 2020 Nov 17

Annals of surgery, 2010-09

Journal of reconstructive microsurgery, 2022 Feb 14

Annals of surgery open : perspectives of surgical history, education, and clinical approaches, 2023 May 02

The Lancet. Oncology, 2011 Dec 13

American journal of hematology, 2022 Jul 05

Blood advances, 2023 Oct 24

Blood, 2018 Aug 14

American journal of hematology, 2016-09

Blood, 2017 Jun 13

Haematologica, 2013-01

The Lancet. Haematology, 2015 May 06

European respiratory review : an official journal of the European Respiratory Society, 2017 Sep 06

Mayo Clinic proceedings, 2017-06

Blood Cancer J, 2022 Sep 14

The Journal of community and supportive oncology, 2014-10

Journal of the National Cancer Institute, 1996-10-16

The oncologist, 2019-03

Breast cancer research and treatment, 2019-04

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2020 Apr 22

Annals of oncology : official journal of the European Society for Medical Oncology, 2020 Sep 23

Annals of surgical oncology, 2020 Oct 30

JAMA oncology, 2021 Jan 01

Annals of oncology : official journal of the European Society for Medical Oncology, 2021 Oct 19

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2023 May 26

Journal of the National Comprehensive Cancer Network : JNCCN, 2020 Sep

Radiology, 2012 Dec 06

J Thorac Oncol, 2023 Feb 23

J Clin Oncol, 2023 Jan 31

Cancer journal (Sudbury, Mass.), 2020 Nov/Dec

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2021 Feb 12

Journal for immunotherapy of cancer, 2021 Aug

International journal of cancer, 2019 Feb 19

The Lancet. Respiratory medicine, 2023 May 05

Annals of surgical oncology, 2019 Jun 21

Lancet Oncol, 2020 Apr 27

JAMA, 2023 Aug 8

Blood, 2017 Jan 31

JAMA oncology, 2024 Jan 01

Clinical breast cancer, 2018 Apr 18

Breast cancer research and treatment, 2011 Jan 08

Blood, 2023 Nov 30

Cancer, 2011-10-01

BMC Cancer, 2006 May 05

International journal of radiation oncology, biology, physics, 1998-07-15

International journal of radiation oncology, biology, physics, 2006-01-01

Blood, 2014 May 29

Blood, 2014 Jun 17

International journal of radiation oncology, biology, physics, 2011 Jan 27

Leukemia & lymphoma, 2021 Feb 03

Dominion law reports, 1990 Mar 30

Blood, 2020 Apr 09

American journal of hematology, 2019-04

Blood advances, 2023 Mar 28

American journal of hematology, 2023 Jul 08

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2021 Dec 13

Blood, 2013-10-24

The Lancet. Oncology, 2018-03

Blood cancer journal, 2024 Apr 15

Blood cancer journal, 2019 Nov 25

British journal of haematology, 2019 Dec 09

The New England journal of medicine, 2023 Dec 12

Blood cancer journal, 2024 Apr 22

Blood advances, 2023 Sep 26

Lancet (London, England), 2019 Dec 10

The New England journal of medicine, 2024 Jun 03

Nature medicine, 2024 Jun 03

Blood, 2023 Jan 19

The New England journal of medicine, 2024 Jun 01

The New England journal of medicine, 2024 Jun 02

Clinical pharmacokinetics, 2017 Feb

Cancer chemotherapy and pharmacology, 2016 Dec 30

Blood cancer journal, 2018-11-19

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2022 Jun 06

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2022 Oct 31

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2022 Jun 06

Transplant Cell Ther, 2023 Mar 17

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2023 Oct 24

Blood advances, 2023 Aug 22

Kidney international, 2018-07

BMC nephrology, 2019-02-14

Leukemia & lymphoma, 2024 Apr 16

International journal of radiation oncology, biology, physics, 2024 Oct 27

Scientific reports, 2022 Nov 29

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009-12-10

Blood, 2015 Jun 24

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009 Oct 05

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006-03-20

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001-05-01

Chinese clinical oncology, 2019 Oct

JAMA Oncol, 2019 Oct 31